Figure 4From: Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients Prognostic impact of s-TATI in Stage II and Stage III disease. Kaplan Meier estimates of disease free survival according to high and low s-TATI levels derived from ROC-analysis in Stage II (A) and Stage III patients (B), and overall survival in Stage II (C) and Stage III patients (D), respectively.Back to article page